Clinical Transplantation

Living donor liver transplant candidate and donor selection and engagement: Meeting report from the living donor liver transplant consensus conference..  e14954. 2023

State of the art – Extracorporeal membrane oxygenation as a bridge to thoracic transplantation.  37. 2023

Variation in adult living donor liver transplantation in the United States: Identifying opportunities for increased utilization 2023

Abnormal time-zero histology is predictive of kidney transplant outcomes.  36. 2022

Donor-reported barriers to living kidney donor follow-up.  36. 2022

Organ transplant and Covid-19 vaccination: Considering the ethics of denying transplant to unvaccinated patients.  36. 2022

Factors associated with telemedicine utilization among post-transplant patients at a university kidney and pancreas transplant center.  36. 2022

Mandating COVID-19 immunization for living organ donors.  36. 2022

Operational challenges in the COVID-19 era: Asymptomatic infections and vaccination timing.  35. 2021

Association between dd-cfDNA levels, de novo donor specific antibodies, and eGFR decline: An analysis of the DART cohort.  35. 2021

Obesity is a risk factor for progression to kidney transplant waitlisting after liver transplantation.  35. 2021

Impact of induction strategy change on first-year rejection in pediatric heart transplantation at a single center—From postoperative basiliximab to either postoperative anti-thymocyte globulin or preoperative basiliximab.  35. 2021

Avoiding surveillance biopsy: Use of a noninvasive biomarker assay in a real-life scenario.  35. 2021

Pig kidney xenotransplantation: Progress toward clinical trials.  35. 2021

Care of international living kidney donor candidates in the United States: A survey of contemporary experience, practice, and challenges.  34. 2020

Genome-wide association study for time to failure of kidney transplants from African American deceased donors.  34. 2020

Evaluation and care of international living kidney donor candidates: Strategies for addressing common considerations and challenges.  34. 2020

Vancomycin-resistant Enterococcus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.  33. 2019

Corticosteroids and methotrexate as adjuvants to costimulation blockade in non-human primate renal transplantation.  33. 2019

The effect of an organ procurement experience on preclinical medical student perceptions of transplant surgery.  33. 2019

Disparity in access to kidney allograft offers among transplant candidates with human immunodeficiency virus.  33. 2019

A quantitative appraisal of African Americans’ decisions to become registered organ donors at the driver’s license office.  32. 2018

Surgical approach, cost, and complications of appendectomy in kidney transplant recipients.  32. 2018

Lung transplantation in cystic fibrosis patients in Israel: The importance of ethnicity and nutritional status.  31. 2017

Patterns of primary care utilization before and after living kidney donation.  31. 2017

Abdominal lean muscle is associated with lower mortality among kidney waitlist candidates.  31. 2017

Colonoscopy bowel preparation quality improvement for patients with decompensated cirrhosis undergoing evaluation for liver transplantation.  30:1236-1241. 2016

Assessment of resident and fellow knowledge of the organ donor referral process.  28:443-449. 2014

Infection and rejection risk after cardiac transplantation with induction vs. no induction: A multi-institutional study.  28:946-952. 2014

Radiation exposure and attributed cancer risk following lung transplantation.  28:324-329. 2014

Renal function preservation with the mTOR inhibitor, Everolimus, after lung transplant.  28:662-668. 2014

Ethnicity, medical insurance, and living kidney donation.  27. 2013

The relationship of socio-demographic factors and satisfaction with social support at five and 10 yr after heart transplantation.  27:267-273. 2013

Treatment options for renal cell carcinoma in renal allografts: A case series from a single institution.  27. 2013

Lung transplantation in patients with coal workers' pneumoconiosis.  26:629-634. 2012

Beyond rose colored glasses: The adaptive role of depressive and anxious symptoms among individuals with heart failure who were evaluated for transplantation.  26. 2012

Results of live donor liver transplantation in patients with hepatitic C virus infection: The HCV 3 trial experience.  26:502-509. 2012

Clarithromycin for prevention of bronchiolitis obliterans syndrome in lung allograft recipients.  26:105-110. 2012

Factors associated with work status at 5 and 10 years after heart transplantation.  25. 2011

Donor-recipient relationships in African American vs. Caucasian live kidney donors.  25. 2011

Short-term renal outcomes in African American and Caucasian donors following live kidney donation.  24:717-722. 2010

Impact of race and gender on live kidney donation.  23:39-46. 2009

Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients.  22:113-119. 2008

Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: A 12-month randomized trial in renal transplant recipients.  21:192-201. 2007

Radiofrequency thermal ablation of hepatocellular carcinoma before liver transplantation - A clinical and histological examination.  20:695-705. 2006

Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: A matched control study.  19:711-716. 2005

Laparoscopic donor nephrectomy vs. open live donor nephrectomy: A quality of life and functional study.  19:102-109. 2005

Pharmacokinetics of daclizumab and mycophenolate mofetil with cyclosporin and steroids in renal transplantation.  17:511-517. 2003

Immune cell function testing: An adjunct to therapeutic drug monitoring in transplant patient management.  17:77-88. 2003

Fungal brain abscess in transplant recipients: Epidemiologic, microbiologic, and clinical features.  16:419-424. 2002

Improved outcomes in cadaveric renal allografts with pulsatile preservation.  14:543-549. 2000

Specificity of preformed alloantibodies causing B cell positive flow crossmatch in renal transplantation.  14:533-542. 2000

Review of select transplant subpopulations at high risk of failure from standard immunosuppressive therapy.  14:439-448. 2000

Immunosuppression tailored to race.  5:580-582. 1991